MTOR and colorectal carcinoma: Bai et al. experimentally confirmed that the effects of larotrectinib (Lar) was able to inhibit the proliferation and migration of CRC cells, and the underlying mechanism was related to the activation of AMPK/mTOR signaling pathway, thus inducing intracellular autophagy (Bo et al., 2024).